Helicobacter pylori, a common pathogen that causes chronic gastritis and cancer, has evolved to establish persistent infections in the human stomach. Epidemiological evidence suggests that H. pylori with both highly active vacuolating cytotoxin A (VacA) and cytotoxin-associated gene A (CagA), the major virulence factors, has an advantage in adapting to the host environment. However, the mechanistic relationship between VacA and CagA remains obscure. Here, we report that CagA interferes with eukaryotic endocytosis, as revealed by genome-wide screening in yeast. Moreover, CagA suppresses pinocytic endocytosis and the cytotoxicity of VacA in gastric epithelial cells without affecting clathrin-dependent endocytosis. Our data suggest that H. pylori secretes VacA to attack distant host cells while injecting CagA into the gastric epithelial cells to which the bacteria are directly attached, thereby protecting these attached host cells from the cytotoxicity of VacA and creating a local ecological niche. This mechanism might allow H. pylori to balance damage to one population of host cells with the preservation of another, allowing for persistent infection.
INTRODUCTION
Helicobacter pylori is present in approximately half of the human population worldwide and often persists as a stomach infection throughout an infected individual's lifetime. During decades of persistent infection, H. pylori can cause gastric diseases such as chronic gastritis, peptic ulcers, and cancer (Blaser and Atherton, 2004; Fukase et al., 2008) that are, at least in part, caused by two well-known virulence factors: vacuolating cytotoxin A (VacA) and cytotoxin-associated gene A (CagA). VacA is secreted from H. pylori and internalized into host cells by endocytosis; this toxin causes cell vacuolation, cell death, an increase in the permeability of gastric epithelium (Cover and Blaser, 1992; Papini et al., 1998; Galmiche et al., 2000) , and gastric ulcers in vivo (Telford et al., 1994; Fujikawa et al., 2003) . VacA is also reported to suppress host defense mechanisms (Molinari et al., 1998; Gebert et al., 2003) . CagA is an effector protein that is injected into host cells through the type IV secretion system (T4SS); cagA and the components of T4SS are encoded by a 40 kb gene cluster known as the cag pathogenicity island (cagPAI) (Censini et al., 1996) . Injected CagA is tyrosinephosphorylated by Src family kinases, and it associates with various host proteins such as SHP2 and GRB2, resulting in functional and morphological changes in host cells (Backert and Selbach, 2008) . It has been proposed that CagA activates a growth-factor-like response (Segal et al., 1999) and disrupts polarity (Amieva et al., 2003) in host cells, thus promoting the survival and motility of the gastric epithelial cells that provide the ecological niche for H. pylori (Rieder et al., 2005; Tan et al., 2009 ). CagA-activated signaling might also account for the pathogenic potential of H. pylori in diseases such as cancer. Indeed, cagPAI is often identified in strains isolated from patients with severe gastric disease, and CagA has been used as a marker of virulent strains .
VacA proteins exhibit considerable sequence variation in the Nterminal signal peptide (s-region), with the two versions termed s1 and s2, and in the middle region (m-region), with versions termed m1 and m2. The s1-m1 VacA has strong vacuolating activity in a wide range of cell types, whereas s1-m2 VacA shows vacuolating activity in a more limited range of cell types. The s2 VacA is virtually nontoxic in cell culture experiments (Cover and Blanke, 2005) . Interestingly, epidemiological data have revealed a strong correlation between cagA and the virulent type of vacA. Most of the strains with s1 VacA showing high vacuolating activity are also positive for CagA, whereas those with s2 VacA lacking vacuolating activity are mostly negative for CagA (Atherton et al., 1995; Van Doorn et al., 1999) . Despite these strong correlations, vacA and cagPAI are physically far apart in the genome of H. pylori (Tomb et al., 1997) , suggesting that a functional connection between VacA and CagA is responsible for the coincidence of s1 VacA and CagA. H. pylori seems to have evolved to maximize genetic diversity by mutation, recombination, and shuffling of the genetic information within the population as an adaptation mechanism (Blaser and Atherton, 2004) . Considering the relatively large size of cagPAI (40 kb), the physical distance between the vacA and cagPAI loci, and the extensive genetic reshuffling observed in H. pylori, it is likely that there is a selective pressure that results in the concurrence of intact cagPAI and highly active VacA genotypes. Although reports have shown functional antagonism between VacA and CagA in host cells in the processes of NFAT (nuclear factor of activated T cells) signaling (Yokoyama et al., 2005) , epidermal growth factor (EGF) receptor signaling (Tegtmeyer et al., 2008) , and morphological change (Asahi et al., 2003; Argent et al., 2008) , the underlying mechanism of the interplay between CagA and VacA remains obscure.
We performed genetic screening to identify the mechanism of action of CagA in eukaryotic cells, using the gene-knockout collection of Saccharomyces cerevisiae (Giaever et al., 2002 ) that has been utilized to elucidate the function of bacterial virulence factors such as IpgB2 and OspF of Shigella (Alto et al., 2006; Kramer et al., 2007) . Here, we report that CagA inhibits endocytosis in yeast cells and human gastric epithelial cells. In the gastric epithelial cell line AGS, CagA specifically inhibited clathrin-independent pinocytic endocytosis, the mechanism by which VacA enters the host cells, without affecting clathrin-dependent endocytosis. Through this mechanism, CagA suppresses the internalization and the function of VacA in the host cells. Based on these findings, we propose that CagA works as a molecular shield against the deleterious effect of VacA in a subset of host epithelial cells, thus maintaining a favorable ecological niche for H. pylori.
RESULTS

Genome-wide screening of CagA function
In an effort to identify the biological process in eukaryotes that is disrupted by CagA, we chose a genetic screening system with a series of Saccharomyces cerevisiae strains that each carry a homozygous deletion of one of 4792 nonessential genes. The deficiency of a single gene in a yeast strain might compromise a specific biological process even though the corresponding strain is still viable. If CagA interferes with the specific biological process compromised by a particular deletion, the strain is expected to be hypersensitive to CagA toxicity. This screening is analogous to the synthetic lethality screening that uses double mutants, and therefore should identify the biological process compromised by CagA, but not necessarily the direct molecular targets of CagA.
A virulent East Asian type of the cagA gene (Azuma et al., 2004) derived from H. pylori CPY2052 was fused to the C-terminus of the green fluorescent protein gene to produce GFP-CagA. When expressed in AGS gastric epithelial cells (Fig. 1A) localized to the cell periphery, underwent tyrosine phosphorylation, and induced cell elongation as previously reported (Segal et al., 1999) , indicating that the GFP-fused CagA is functionally active. We expressed GFP-CagA or the GFP control in wild-type yeast under the control of the GAL10 promoter, a galactose-inducible and glucose-repressible promoter. GFP-CagA localized to the periphery of the yeast cells, whereas GFP alone was distributed throughout the cytoplasm (Fig. 1A) . GFP-CagA did not induce morphological changes in yeast (Fig. 1A) , nor did it undergo tyrosine phosphorylation (supplementary material Fig. S1 ), probably because yeast does not have a Src-family kinase (Manning et al., 2002) . Induction of CagA inhibited the growth of yeast moderately at 28°C and severely at 37°C (Fig. 1B, WT) .
We next screened all 4792 deletion strains by expressing CagA in each strain; we identified 18 strains with hypersensitivity to the CagAinduced growth defects (Set I in Table 1; Fig. 1B; supplementary  material Figs S2, S3; see Methods) . Strikingly, half of the 18 genes identified are implicated in transport (RVS161, MYO5, VPS60, NUP188, FET3, VPS27, VPS24, BRO1 and DID2) sorting (Vps) proteins required for the formation of late endosomes and vesicular transport to vacuoles, the yeast equivalent of mammalian lysosomes (Katzmann et al., 2002; Williams and Urbe, 2007) , whereas the RVS161 and MYO5 gene products are involved in the initial step of endocytosis (Kaksonen et al., 2006) . We performed another set of screening with a series of heterozygous deletion strains for 1139 essential genes, resulting in the identification of a single strain with CagA hypersensitivity (Set II in Table 1 and Fig. 1B ; supplementary material Fig. S2 ; see Methods). This strain harbored a heterozygous deletion of ACT1, an actin-encoding gene involved in endocytosis and vesicular transport (Kaksonen et al., 2006) . Hence, eight of the 19 genes (Table 1 ) identified in our screening were associated with endocytosis pathways.
CagA expression inhibits endocytosis in yeast
To test the effects of CagA on yeast endocytosis more directly, we monitored endocytosis in wild-type yeast cells expressing either GFP or GFP-CagA by staining with a membrane-lipid probe, FM4-64. Cells expressing the control GFP construct readily formed endocytic vesicles (endosomes) upon shifting from 0°C to 25°C as shown by the FM4-64 staining (Fig. 1C, arrowheads) . Within 60 minutes of the temperature shift, FM4-64 fluorescence was apparent in the membranes of vacuoles (Fig. 1C, arrows) . By contrast, very few endosomes appeared in cells expressing GFPCagA after 60 minutes, and vacuoles were only weakly stained (Fig.  1C ). Quantitative analysis of the stained endosomes ( Fig. 1D ) and vacuoles ( Fig. 1E) showed that GFP-CagA expression dramatically reduces the trafficking of FM4-64 from the plasma membrane to endosomes and ultimately to vacuoles. The low frequency of stained endosomes in GFP-CagA-expressing cells indicates that CagA inhibits an early stage of endocytosis in yeast, consistent with the localization of CagA at the plasma membrane.
CagA expression inhibits pinocytic endocytosis in AGS cells
The endocytosis machinery of yeast and mammalian cells share many homologous molecules. In fact, all the endocytic genes identified in our screening have mammalian orthologs (Table 1) . We examined the endocytic activities of AGS cells expressing either GFP or GFP-CagA, using FM4-64FX as a membrane-lipid probe.
In contrast to our observations in yeast, GFP-CagA did not have an obvious impact on the formation of FM4-64FX-positive endosomes in AGS cells ( Fig mechanism on certain molecules, such as clathrin (Mayor and Pagano, 2007) . We next examined the effect of CagA on the endocytosis of cholera toxin subunit B (CT-B), which is internalized by a clathrin-independent mechanism. Incubation of AGS cells with the fluorescently labeled CT-B at 0°C resulted in attachment of CT-B to the plasma membrane. Temperature shift from 0°C to 37°C caused rapid internalization of CT-B within 20 minutes, resulting in the formation of multiple CT-B-positive endosomes (Fig. 2B) . Expression of GFP did not have an obvious impact on CT-B binding to the plasma membrane or subsequent endocytosis. Expression of GFP-CagA did not have an effect on the initial binding of CT-B to the plasma membrane; however, relative to the controls, AGS cells expressing GFP-CagA formed fewer CT-B-positive endosomes within the first 20 minutes after the temperature shift ( Fig. 2C ), in sharp contrast to the endocytosis observed using FM4-64FX. These results suggest that CagA might inhibit a subset of endocytic pathways in AGS cells (Fig. 2B,C) .
CT-B is mainly internalized by a clathrin-independent endocytosis pathway characterized by fluid-phase-marker cargos (Mayor and Pagano, 2007) . We examined the effect of GFP-CagA on the uptake of dextran, a fluid-phase marker (Sabharanjak et al., 2002) . Expression of CagA significantly inhibited the formation of dextran-positive endosomes compared with the neighboring cells without GFP-CagA expression (Fig. 3A,B) . GFP-expressing cells showed no difference in the formation of dextran-positive endosomes compared with nontransfected cells (Fig. 3A,B) . We also examined endocytic activities of AGS cells using transferrin, a classical clathrin-dependent endocytosis cargo molecule (Fig. 3C, D) . Consistent with the notion that CagA inhibits a subset of mammalian clathrin-independent endocytosis pathways, GFPCagA did not cause an obvious delay in the uptake of transferrin. Taken together, these observations indicate that CagA inhibits clathrin-independent endocytosis of the fluid-phase marker dextran, without disrupting clathrin-dependent endocytosis of transferrin. In this study, we use the term pinocytic endocytosis, which is operationally defined by the internalization of the fluidphase marker dextran, for the CagA-inhibited endocytosis pathway. Although this pinocytic endocytosis is poorly characterized and might be heterogeneous in nature (Mayor and Pagano, 2007) , it has been proposed that it might represent a primordial endocytic pathway similar to yeast endocytosis (Kirkham and Parton, 2005) . . S5 ), consistent with a previous report (Gauthier et al., 2005) and our finding that CagA suppresses endocytosis of dextran. These observations indicate that CagA in AGS cells inhibits pinocytic endocytosis of VacA without affecting VacA attachment to the plasma membrane. Recent studies suggested that ectopically expressed CagA might behave differently from native CagA injected by H. pylori through T4SS (Higashi et al., 2002; Amieva et al., 2003; Kwok et al., 2007) . We therefore examined the effect of H. pylori-injected CagA on VacA endocytosis. We generated various isogenic deletion mutants of H. pylori for cagA (V+C-), vacA (V-C+) or both (V-C-) from wild-type H. pylori CPY2052, which produces a virulent-type s1-m1 VacA (supplementary material Fig. S6 ) and CagA (V+C+). Immunoblot analyses showed that deletion of either vacA or cagA did not affect the expression level of the other (Fig. 5A) . Infection of AGS cells with the cagA + (C+) strains resulted in the appearance of tyrosine-phosphorylated protein in the infected cells that corresponded to the molecular weight of CagA (Fig. 5A) , indicating the successful injection of CagA from H. pylori into AGS cells. We stained AGS cells for VacA 5 hours after the infection with either V+C+ or V+C- (Fig. 5B) . VacA from V+C+ mostly stayed on the plasma membrane of AGS cells (Fig. 5B, arrowheads) , and showed limited cytoplasmic vesicular staining, 5 hours after the infection. By contrast, AGS cells with V+C-infection showed strong cytoplasmic vesicular and vacuole membrane staining of VacA (Fig.  5B, arrows) . We obtained similar results when we used the Western H. pylori strain NCTC11637, which possesses a Western-type cagA gene (Azuma et al., 2004 ) (supplementary material Fig. S7 ). These findings suggest that VacA stays on the plasma membrane in the presence of CagA at least for some time, whereas VacA rapidly enters host cells in the absence of CagA.
CagA inhibits endocytosis of VacA
In the infection experiments described above, two processes take place at the same time: the uptake of H. pylori-secreted VacA by AGS cells and the accumulation of H. pylori-injected CagA in AGS cells. The CagA-mediated inhibition of endocytosis presumably depends on the accumulation of CagA in the host cells. This accumulation of intracellular CagA might take some time, and therefore CagA-mediated inhibition of VacA endocytosis might not be obvious at an early time point in the infection. To segregate these two processes, we first infected AGS cells for 2 days either with V-C+ to let H. pylori inject CagA into AGS cells or with V-C-as a negative control. Immunoblot analyses showed that infection of AGS cells with V-C+ resulted in the appearance of tyrosinephosphorylated CagA, confirming the successful injection of CagA by V-C+ H. pylori under our experimental conditions (supplementary material Fig. S8 ). We then added gentamycin to eliminate H. pylori, and purified VacA to monitor VacA endocytosis (Fig. 5C ). Immunostaining of VacA in AGS cells with V-Cinfection showed VacA-positive endosomes as early as 1 hour after the addition of purified VacA (Fig. 5C, right were formed 13 hours after the addition of purified VacA. By contrast, VacA staining in AGS cells with V-C+ infection showed the accumulation of VacA predominantly on the plasma membrane (Fig. 5C , left panels, arrowheads) at 1 hour and 3 hours after the addition of purified VacA. VacA then moved to endosomes by 13 hours. We also noticed that 13 hours after the addition of purified VacA, AGS cells infected with V-C+ showed much less vacuolation than the cells infected with V-C-. These observations indicate that native CagA, injected by H. pylori, inhibits VacA entry into the host cells, and might inhibit the VacA-mediated vacuolation of the host cells.
CagA inhibits VacA function in AGS cells
We next examined whether the inhibition of VacA endocytosis by CagA had any impact on the microbe-host interaction in terms of VacA function in host cells. We performed an assay of Neutral Red uptake to quantify vacuolation, the best-characterized VacA function, in infected cells. Infection of AGS cells with V+C+ H. pylori caused vacuolation as demonstrated by the high level of Neutral Red uptake. The V--infected AGS cells showed low levels of Neutral Red uptake that were comparable to levels seen in the noninfected cells (Fig. 6A,B ). Infection with V+C-H. pylori caused significantly more vacuolation than that with V+C+ H. pylori, and the difference remained significant during the observation period of 5 hours (Fig. 6B) . To further analyze the effects of injected CagA on VacA functions, we infected AGS cells for 2 days with V-C+ to allow the bacteria to inject CagA into AGS cells or with V-C-as a negative control (Fig. 6C ). We then eliminated the H. pylori with gentamycin and incubated the AGS cells with the VacA-containing culture supernatant of V+C+ H. pylori (VacA sup) to induce vacuolation (Fig. 6C, left) . After treatment with VacA-containing H. pylori culture supernatant, AGS cells infected with V-C+ showed significantly lower vacuolation than those infected with V-C-. We obtained essentially identical results when we used purified VacA to induce vacuolation (Fig. 6C, right) .
We also examined the effect of the injected CagA on the apoptosis-inducing activity of VacA in AGS cells. We infected AGS cells with V-C-, V-C+, V+C-or V+C+ H. pylori and determined apoptosis of AGS cells by nuclear condensation as detected by Hoechst 33342 staining (Fig. 6D,E (Cover and Blanke, 2005) .
It has been proposed that VacA allows H. pylori to obtain nutrients from host cells and to evade host-cell attacks by damaging them, thus facilitating colonization and/or persistent infection (Blaser and Atherton, 2004; Amieva and El-Omar, 2008) . However, excessive damage to the gastric epithelium by VacA might be disadvantageous for H. pylori, because viable gastric epithelial cells produce a mucous layer, an essential ecological niche for H. pylori (Rieder et al., 2005; Amieva and El-Omar, 2008) , and the epithelial cell surface provides a replicative niche for the bacteria (Tan et al., 2009) . Therefore, H. pylori must have evolved ways of balancing the preservation of and the damaging of host cells in order to establish and maintain persistent infection (Blaser and Kirschner, 2007) . Based on our findings, we propose that CagA works as a molecular shield against VacA in epithelial cells (supplementary material Fig. S9 ). When VacA-secreting H. pylori adheres to a host gastric epithelial cell, it injects CagA into that host cell; the CagA, in turn, protects that host cell from the excessive damage potentially caused by VacA. By contrast, host cells without CagA (epithelial cells without adherent H. pylori) and infiltrating immune cells are damaged by fully active VacA, allowing H. pylori to obtain nutrients from distant cells subjected to VacAdependent damage and to fight host immune cells, while simultaneously maintaining its nearest gastric epithelial neighbors as viable host cells through injected CagA. This model provides a mechanistic explanation for the epidemiological linkage between CagA and the virulent-type VacA (Atherton et al., 1995; Van Doorn et al., 1999) . Although the large cagPAI might be lost during chronic
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Helicobacter CagA inhibits endocytosis RESEARCH ARTICLE infections in humans (Kersulyte et al., 1999; Suerbaum and Josenhans, 2007) , highly active s1 VacA might provide a selection pressure that keeps cagPAI intact in the population. By contrast, H. pylori strains with less virulent s2 VacA would not experience such a strong selection pressure and are thus more prone to lose intact cagPAI because of the high rates of mutation and recombination in this pathogen (Blaser and Atherton, 2004; Suerbaum and Josenhans, 2007) .
Apart from the inhibition of VacA function, CagA-mediated inhibition of pinocytic endocytosis would disturb the normal physiology of host cells, such as the turnover of cell-surface molecules. Indeed, it was recently reported that CagA sustains the cell-surface expression of EGF receptor by inhibiting its internalization (Bauer et al., 2009 ). We also observed that CagA inhibited the internalization of EGF receptor (supplementary material Fig. S10 ) as well as receptor tyrosine phosphatase  (RPTP) (supplementary material Fig. S11) , one of the VacA receptors. Notably, it has been reported that clathrin-independent endocytosis directs the EGF receptor to degradation, whereas clathrin-dependent endocytosis is essential for the sustained EGF signaling as this pathway recycles the EGF receptor back to the cell surface (Sigismund et al., 2008) . Because CagA does not seem to interfere with clathrindependent endocytosis, it might selectively suppress the degradation of the EGF receptor without interfering with clathrin-dependent signaling. Inhibition of pinocytic endocytosis by CagA might also be involved in other effects of CagA, including the disruption of cell polarity and tight junctions (Backert and Selbach, 2008) , as these host functions require normal endocytosis for their maintenance (Le et al., 1999; Yu and Turner, 2008) . Whether CagA-mediated inhibition of pinocytic endocytosis is involved in these effects of CagA awaits further clarification of the molecular mechanisms by which CagA inhibits pinocytic endocytosis, a process that is poorly characterized at this time (Mayor and Pagano, 2007) .
Interestingly, a functional linkage between VacA and CagA, complementary to our findings, has been reported. Specifically, highly active VacA suppresses CagA-induced elongation of AGS cells by inhibiting EGF receptor signaling (Tegtmeyer et al., 2008) . We also observed that V-C+ H. pylori tended to cause more prominent cell elongation of AGS cells than V+C+ (data not shown). Very recently, Oldani et al. reported that forced expression of the C-terminal fragment of CagA interferes with the intracellular trafficking of VacA after endocytosis (Oldani et al., 2009) . Combined with our findings, their results might suggest that CagA domain(s) outside of the Cterminal region might be required for the full suppression of VacA endocytosis. Nonetheless, their conclusion is consistent with ours in that CagA suppresses VacA-mediated cytotoxicity. Presumably, such functional antagonism would depend on the timing and the dynamic equilibrium of CagA accumulation and VacA uptake in host cells during chronic gastric infection with genetically heterogenous H. pylori. Therefore, the emerging theme is that these two major virulence factors are tightly coupled in their functions, and the balance of their activities is crucial for the successful adaptation of H. pylori to its host environment. Elucidation of the molecular mechanisms of CagA-mediated inhibition of pinocytic endocytosis will provide us with a better understanding of the biology of H. pylori and of the pathophysiology of the diseases associated with H. pylori infection, both of which are essential for developing new therapeutics and management strategies for H. pylori-associated diseases, including cancer.
METHODS
H. pylori and AGS cells
Helicobacter pylori strain CPY2052 was isolated from a gastric ulcer patient at Yamaguchi University Hospital, Japan (Tsuda et al., 1993) . H. pylori strains CPY2052 and NCTC11637 were cultured on Brucella agar plates containing 5% or 10% fetal bovine serum (FBS) under 10% CO 2 at 37°C. AGS cells (ATCC CRL1739), which were derived from a human gastric adenocarcinoma, were grown in RPMI1640 medium containing 10% FBS (AGS medium) and transiently transfected with the indicated plasmids using FuGENE6 (Roche Diagnostics) for 1 day.
CagA gene and plasmids
The cagA gene was cloned from the genomic DNA of H. pylori strain CPY2052. The cagA fragment (GenBank accession numbers DQ091000 and AAZ23952 for cDNA and the deduced amino acid sequence, respectively) was inserted into the mammalian expression vector pEGFP-C1 (expression vector of GFP in AGS cells in the main text), producing plasmid pJ2022 (expression vector of GFP-CagA in AGS cells in the main text). For expression of CagA in yeast, the cagA gene from pJ2022 was inserted into p316GAL (Kawahata et al., 1999) , producing plasmid pJ2082. The yeastoptimized GFP (yEGFP) cDNA (Cormack et al., 1997 ) from pK11 (a gift from Dr Susan C. Straley, University of Kentucky, USA) was inserted into the p316GAL to construct p316GAL-yEGFP (expression vector of GFP in yeast in the main text). The cagA gene from pJ2022 was subcloned into p316GAL-yEGFP to construct p316GAL-yEGFP-CagA, producing plasmid pJ2531 (expression vector of GFP-CagA in yeast in the main text). All of the constructs were confirmed by DNA sequencing at the Center for Gene Research, Yamaguchi University, Japan.
Yeast
The Saccharomyces cerevisiae BY4743 strain (MATa/MATa leu2D0/leu2D0 ura3D0/ura3D0 his3D1/his3D1 met15D0/+ +/lys2D0), the 4792 homozygous diploid deletion strains (#95401.H1R3) (described as Set I in this paper) and the 1139 heterozygous diploid deletion strains (#95401.H5R3) (Set II in this paper) were purchased from Research Genetics (AL, USA). Yeast cells were grown on standard YPD medium and dropout synthetic medium. One-by-one yeast transformation was performed as previously described (Chen et al., 1992) . Transformed yeast cells were grown in uracil-dropout 2% raffinose (-U'Raf ) liquid medium for 1 day at 28°C. 10 ml aliquots of yeast cell suspensions (with calculated OD 600 of 1.0, 0.1, 0.01 and 0.001) were then spotted onto uracil-dropout medium plates containing 2% glucose (-U'Glc) or 2% galactose (-U'Gal) and incubated at either 28°C or 37°C for 3-6 days. For liquid culture, uracil-dropout 2% raffinose + 2% galactose (-U'Raf/Gal) medium was used. Synthetic complete medium containing glucose (SCGlc), galactose (SCGal) and raffinose (SCRaf ) was used for the selection of deletion strains. Synthetic minimal medium containing only leucine, histidine and uracil (SM) was used for the confirmation of diploid strains.
Screening in yeast
Transformation of wild-type and deletion strains of S. cerevisiae was carried out with pJ2082 on 96-well plates using the S. cerevisiae Direct Transformation Kit (Kitagawa et al., 2007) (Wako, Osaka, Japan). Transformed cells were selected with a 96-well-format picker (Genetyx), suspended in 25 ml of -U'Raf medium in 96-well plates, and cultured overnight at 28°C. The tenfold dilutions of these cultures were then spotted on -U'Gal plates and incubated at 28°C and 37°C for 5 days, and strains with lower growth rate than wild type were selected to obtain 124 strains of Set I and 28 strains of Set II (Step 1 of Set I and II; supplementary material Fig. S2 ). For further growth determination, strains grown in -U'Raf medium were spotted onto -U'Gal or -U'Glc plates as tenfold serial dilutions. The growth of each strain was given a score between 0 and 4, where 0 indicates that the original undiluted (OD 1.0) spot did not grow, 1 indicates the OD 1.0 spot grew but OD 0.1 spot did not, and 4 indicates the OD 0.001 spot grew. CagA-expressing strains with a growth score of 3 or less on -U'Gal plates were selected to obtain 94 strains from Set I and four strains from Set II (Step 2 of Set I and II). The 94 selected Set I deletion strains were grown without transformation at 28°C and 37°C on SCGal plates, and their growth was compared with that on SCGlc and SCRaf plates to assess their temperature sensitivities on galactose. Strains with slow growth on SCGal plates were eliminated, resulting in 72 strains from Set I (Step 3 of Set I). The growth score of the CagA-expressing strains on -U'Gal plates at day 4 was subtracted from that with the empty vector to obtain the CagA sensitivity score, which is expressed as -, +, ++, +++ and ++++ , as shown in Table  1 , and the strains that scored ++ or more at 28°C and/or +++ or more at 37°C were selected to give a total of 23 strains from Set I and one strain from Set II (Step 4 of Set I and Step 3 of Set II). The remaining 23 strains of Set I were transformed with the uracilcomplementing p316GAL vector, and the transformed strains were assessed for temperature sensitivity on -U'Gal at 28°C and 37°C to confirm strain quality following auxotrophic growth on SM medium. This step resulted in the elimination of two strains from Set I (Step 5 of Set I). The remaining 21 strains of Set I with the CagA-expressing plasmid were grown in 2 ml of -U'Raf or -U'Raf/Gal liquid media with vigorous shaking at 28°C or 37°C for 5 hours, and the protein expression level of CagA was monitored by comparing it with that of actin by immunoblotting. The CagA detection level was normalized using the actin level in each strain, where the calculated fold of the relative CagA:actin expression of each strain is 1 for wild type (supplementary material Fig. S3 ). If the strain value was more than 1.5-fold greater than the wild-type value at both 28°C and 37°C, we judged it as a high-CagAexpressing strain and eliminated it. After this process, 18 strains from Set I remained (Step 6 of Set I). The final 18 strains of Set I and one strain of Set II are indicated in Table 1 .
Immunodetection
Proteins were detected by immunoblotting using antibodies for CagA (Austral Biologicals), phosphotyrosine (4G10, Upstate), actin (Santa Cruz Biotechnology), VacA (Yahiro et al., 1999) and UreA (Institute of Immunology).
Endocytosis assay
Endocytosis in yeast was assessed as reported previously (Vida and Emr, 1995) . Briefly, the yeast strain BY4743 expressing either GFP or GFP-CagA was grown in 1 ml of −U'Raf liquid medium overnight, and a 1:20 dilution of the cell suspension was cultured in −U'Raf/Gal medium for 1 day. Cells were labeled with 40 mM FM4-64 (Invitrogen) in fresh medium for 30 minutes on ice. The cells were observed under a fluorescence microscope (Olympus) at 25°C. More than 30 cells expressing moderate levels of GFP or GFP-CagA from six independent colonies were counted to calculate the frequency of the indicated phenotypes.
For the endocytosis assay in mammalian cells, AGS cells expressing GFP or GFP-CagA were cultured on gelatin-coated cover slips, pre-chilled on ice with AGS medium supplemented with 5 mM HEPES (pH 7.4; HEPES medium) for 15 minutes. For the membrane-lipid probe FM4-64FX (Invitrogen), AGS cells were incubated with 4 mM FM4-64FX on ice for 30 minutes, followed by fixation immediately (0 minutes) or 20 minutes after the incubation at 37°C. For the CT-B-uptake assay, AGS cells were incubated with Alexa-Fluor-555-CT-B (Invitrogen; 1 mg/ml in HEPES medium) on ice for 30 minutes, followed by fixation immediately (0 minutes) or 20 minutes after incubation at 37°C. For the dextran-uptake assay, AGS cells were incubated with 70 kDa dextran conjugated with tetramethylrhodamine (Molecular Probes; 10 mg/ml in HEPES medium) on ice and incubated for 20 minutes at 37°C, followed by fixation for 2 hours for co-staining with VacA, or 5 hours for detecting dextran alone. For the VacAuptake assay, AGS cells were incubated with 10 mg/ml ( Fig. 2A) or 2 mg/ml (all other figures) of acid-activated s1-m1 VacA from ATCC49503 (Nakayama et al., 2004) in HEPES medium for 30 minutes on ice, washed with the HEPES medium, and fixed immediately (0 minutes), or 20 or 90 minutes after shifting to 37°C. 2 mg/ml and 10 mg/ml of VacA showed comparable results in endocytosis assays. VacA was detected by indirect immunofluorescence staining using VacA antibodies. Where indicated, fixed cells were stained by Alexa-Fluor-633-labeled wheat-germ agglutinin (Invitrogen; WGA, 10 mg/ml in PBS) for 30 minutes on ice before permeabilization to visualize the plasma and nuclear membranes. Fluorescence images were obtained using a confocal microscope (LSM5 Pascal and LSM510META, Carl Zeiss) at the Institute for Biomedical Research and Education, Yamaguchi University, Japan. For the quantitative endocytosis assay, z-series of optical sections of 1 mm were obtained from randomly chosen fields. The probed vesicles in the cytoplasm, as determined by the WGA staining, were counted manually in all optical sections in a given field. 30 to 50 cells, all from five to ten randomly chosen fields, were counted in each experimental group for the quantitative endocytosis assays.
H. pylori deletion mutants for cagA and/or vacA The cagA gene was deleted in H. pylori strain CPY2052 or in NCTC11637 by homologous recombination using a targeting vector containing 0.8 kb of the 5Ј region of cagA, the kanamycin-resistance cassette (kan) from pUC4K (GE Healthcare Biosciences), and 1.3 kb of the 3Ј flanking region of cagA. The vacA gene was deleted using a targeting vector consisting of 0.7 kb of the 5Ј flanking region of vacA, the chloramphenicol-resistance cassette (cat) (Wang et al., 1993) , and 1.8 kb of the 3Ј flanking region of vacA. The cagA-and vacA-deletion strains were selected on plates containing 5 mg/ml kanamycin or 8 mg/ml chloramphenicol, respectively. The cagA-and vacA-double-deletion mutant was obtained from the cagA-deletion mutant by additional transformation with the vacA-targeting vector. The identity of the H. pylori deletion mutants was confirmed by PCR and immunoblotting.
dmm.biologists.orgInfection of AGS cells with H. pylori H. pylori strain CPY2052 or NCTC11637 and the isogenic mutants were cultured on Brucella agar plate containing 5% FBS under 10% CO 2 at 37°C for 1 day prior to the infection. Fresh H. pylori culture was suspended in AGS medium. AGS cells in 6-, 12-or 24-well plates were infected with the indicated strain of H. pylori at a multiplicity of infection of 100, and cultured at 37°C under 10% CO 2 for the indicated period. For infection longer than 1 day, culture medium and floating H. pylori were changed into fresh medium once a day. The protein expression levels were analyzed in the culture media and cell pellet by immunoblotting as indicated.
VacA
Purified s1-m1 VacA was prepared from the culture supernatant of H. pylori ATCC49503 as previously described (Nakayama et al., 2004) . Purified VacA was stored at -80°C and acid-activated before use as described (de Bernard et al., 1995) . The vacA genotype of H. pylori strain CPY2052 was determined by PCR using the primers as reported (Atherton et al., 1995) . The Asian-specific middle region was determined using the specific primers as reported (Pan et al., 1998) . VacA-containing culture supernatant of V+C+ H. pylori (VacA sup) was prepared fresh on the day of the experiment. Wildtype H. pylori CPY2052 was cultured in 12 ml of AGS medium (starting OD 590 is 0.1) in 10 cm culture plates without shaking at 37°C, under 10% CO 2 for 4 hours. The cultured medium was centrifuged at room temperature; the resulting supernatant was filtrated with a 0.22 mm filter and used as the VacA sup.
Vacuolation assay
After 2 or 5 hours of co-culture of AGS cells and H. pylori (genotypes V-C-, V-C+, V+C-or V+C+), the medium containing the bacteria was replaced by AGS medium containing 60 mg/ml gentamycin and the cells were then incubated for a further 16 hours to develop vacuoles. To determine the effects of exogenously added VacA, AGS cells were infected with vacA-deleted H. pylori strains (genotype V-C+ and V-C-); the medium was then replaced by VacA sup with 60 mg/ml gentamycin and cells were incubated for 20 hours, or the medium was replaced by AGS medium containing 2 mg/ml purified VacA and 60 mg/ml gentamycin, and cells were incubated for 13 hours.
For both experiments, the quantitative vacuolation assay was performed using Neutral Red as previously described (Cover et al., 1991) , with minor modification. Infected cells in a 24-well plate were incubated in 250 ml of PBS containing 0.05% Neutral Red and 0.3% BSA for 5 minutes and washed three times with 500 ml of PBS containing 0.3% BSA. Neutral Red was extracted with 250 ml of 70% ethanol plus 0.4% HCl, diluted tenfold with 70% ethanol, and quantified by absorption at 540 nm in cuvettes of 1 ml. The OD value observed for each mock infection of no H. pylori (None) was designated as 1 (OD 540 is 0.06-0.08). For the assay of 2-day-infected AGS cells after exogenous VacA addition, the value for AGS cells infected with each strain with VacA addition was normalized by that without VacA addition as 1 (OD 540 is 0.10-0.15). The assays were repeated in three or four wells for each treatment group.
Apoptosis assay
The AGS cells cultured in 24-well plates were infected with the indicated strains of H. pylori for 2 days. Hoechst 33342 (10 mM) was add to live infected cells for 10 minutes then fixed. Under the fluorescent microscope, more than 200 nuclei were counted from all the cells in four randomly chosen fields. The percentage of apoptotic cells (%) was calculated as the percentage of condensed nuclei in total counted nuclei. The averaged data from four fields represented each well. The assay was repeated in four wells for each treatment group.
EGFR and RPTP internalization
For the assessment of EGFR internalization from the plasma membrane, AGS cells were incubated with antibody raised against the extracellular domain of EGFR (Santa Cruz Biotechnology; 0.25 mg/ml in HEPES medium) in serum-free medium for 30 minutes on ice, washed with ice-cold HEPES medium, and then incubated with EGF (Upstate Biotechnology; 100 ng/ml in HEPES medium)
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Stomach infection with the bacterium Helicobacter pylori affects billions of people worldwide. The infection, which is usually established during infancy and persists throughout the life of infected individuals, occasionally causes stomach diseases such as chronic gastritis, peptic ulcers and gastric cancers. H. pylori produces two main virulence factors: VacA, a toxin secreted into the extracellular space that enters host cells and causes cellular damage; and CagA, which for unknown reasons is directly injected into the gastric epithelial cells to which the bacteria are attached. H. pylori strains isolated from patients are genetically heterogeneous for these two factors. CagA is often identified in strains isolated from patients with severe gastric disease, and has thus been used as an indicator of virulent strains. Such CagA-positive strains almost always also express a toxic form of VacA, whereas CagA-negative strains usually express a nontoxic form of VacA. The nature of the relationship between these two virulence factors has been a long-standing enigma of H. pylori.
Results
By carrying out genome-wide screening in yeast, as well as experiments in gastric epithelial cells for CagA function, the authors show that CagA specifically inhibits the clathrin-independent pinocytic endocytosis pathway without affecting clathrin-dependent endocytosis. Because VacA enters into host gastric epithelial cells by pinocytic endocytosis, CagA inhibits the entry and function of VacA in the host cells, thereby protecting them from VacAmediated toxicity. The authors also demonstrate that CagA inhibits the uptake of EGF receptor and RPTP from the host plasma membrane, which depends, at least in part, on the pinocytic endocytosis pathway. 
Implications and future directions
